ESPR earnings: a positive outcome, +11.8%

On May 7, 2024, Esperion Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +11.8% in the window around the event. It had already run -35.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.